Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance rangeExciting development-stage pipeline with ...
Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program
Royalty Pharma plc to become an integrated company by acquiring its external manager, RP Management, LLCSignificant annual cash savings of ...
Delta Air Lines, Walgreens and TSMC rise premarket; Nvidia, AMD fall
Taiwan Semiconductor Manufacturing (NYSE: TSM) stock rose 1.2% after the world’s biggest contract chipmaker reported ...
Pfizer (NYSE:PFE) Price Target Lowered to $29.00 at UBS Group
Pfizer (NYSE:PFE – Get Free Report) had its price objective lowered by analysts at UBS Group from $31.00 to $29.00 in a ...
Pfizer (NYSE:PFE) Stock Price Down 0.8% on Analyst Downgrade
Pfizer Inc. (NYSE:PFE – Get Free Report)’s share price fell 0.8% during trading on Thursday after UBS Group lowered their price target on the stock from $31.00 to $29.00. UBS Group currently has a ...
Royalty Pharma Announces Dividend Increase
Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2025 of $0.22 per Class A ordinary share, reflecting a 5% increase in the ...
California Healthline22h
California Healthline Daily Edition
Hospitals Open For Now As LA Fires Worsen: Hospitals in Los Angeles County remained operational as of Wednesday evening, though several health systems have shuttered clinical locations and physician ...
Pfizer Inc. (NYSE:PFE) is largely controlled by institutional shareholders who own 68% of the company
Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...